BJDX News | Roxom Stocks

1 BTC

- USD

Loading market data...

Mkt Cap

$806,353

Volume

74.69K

Next Earnings

November 6th

Chart Financials Earnings News About Insider Filings

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq RulesBluejay Diagnostics closed a private placement raising $8.5 million upfront with up to $15.2 million in potential additional proceeds from warrant exercises. The company plans to use net proceeds for FDA approval efforts, R&D activities, and working capital, with cash runway expected to extend into Q1 2027 and potentially beyond FDA approval if warrants are fully exercised.GlobeNewswire Inc. · Jun 6, 2026

What's Going On With Bluejay Diagnostics Shares On Wednesday?Bluejay Diagnostics (BJDX) shares traded down 1.84% on Wednesday despite positive developments. The company announced a private placement raising up to $23.6 million ($8.5M upfront plus $15.1M from warrant exercises) to extend cash runway into early 2027 ahead of FDA submission. The company also partnered with Argonaut Manufacturing Services to establish U.S.-based manufacturing capabilities for its Symphony sepsis testing platform. While the stock showed strong momentum (77.52 score), the recent price action suggests caution as it approaches overbought conditions.Benzinga · Jun 3, 2026

Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual MeetingBluejay Diagnostics, Inc. announced that an abstract related to its Symphony IL-6 Test has been accepted for presentation at the 2025 SAEM Annual Meeting. The presentation will focus on results from the SYMON-I pilot clinical study, which evaluated IL-6 as a prognosticator for sepsis patients.GlobeNewswire Inc. · Apr 15, 2025

Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public OfferingACTON, Mass., June 28, 2024 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, today announced the closing of a firm commitment underwritten public offering with gross proceeds to the Company expected to be approximately $8.75 million, before deducting underwriting discounts and other estimated expenses payable by the Company. The base offering consisted of 5,368,098 Common Units or Prefunded Units, each Unit consisting of one share of the Company’s common stock (“Common Stock”) or one pre-funded warrant to purchase one share of Common Stock (each, a “Prefunded Warrant”), two Class C warrants each to purchase one share of our common stock (each, a “Class C Warrant”) and one Class D Warrant to purchase such number of shares of common stock as determined in the Class D Warrant (each, a “Class D Warrant” and together with the Class C Warrants, the “Common Warrants”). The purchase price of each Common Unit is $1.63, and the purchase price of each Prefunded Unit is $1.6299 (which is equal to the public offering price per Common Unit minus $0.0001). The Prefunded Warrants will be immediately exercisable and may be exercised at any time until all the Prefunded Warrants are exercised in full.GlobeNewswire Inc. · Jun 28, 2024

SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis PatientsResults from primary analysis of the SYMON-I pilot clinical study consistent with IL-6 as a predictor of patients who have a mortality event with 28 days after sepsis and septic shock diagnosis and are admitted to the intensive care unit (ICU). Results from primary analysis of the SYMON-I pilot clinical study consistent with IL-6 as a predictor of patients who have a mortality event with 28 days after sepsis and septic shock diagnosis and are admitted to the intensive care unit (ICU).GlobeNewswire Inc. · Jun 26, 2024

Why ZIM Integrated Shipping Services Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving PremarketZIM Integrated Shipping Services Ltd. (NYSE: ZIM) shares rose sharply in today's pre-market trading after Jefferies upgraded the stock from Hold to Buy and raised its price target from $14 to $20. ZIM Integrated Shipping Services shares climbed 9.2% to $14.72 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers NovaBay Pharmaceuticals, Inc. (NYSE: NBY) gained 71.3% to $0.2810 in pre-market trading after gaining around 8% on Friday. NovaBay Pharmaceuticals and Sonoma Pharmaceuticals recently agreed to market Avenova-branded products in the European Union. Spectral AI, Inc. (NASDAQ: MDAI) gained 33.9% to $3.63 in pre-market trading after gaining more than 35% on Friday. BTIG analyst Ryan Zimmerman recently initiated coverage on Spectral AI with a Buy rating and announced a price target of $4. TuanChe Limited (NASDAQ: TC) shares jumped 31.4% to $3.10 in pre-market trading after jumping more than 10% on Friday. Jianzhi Education Technology Group Company Limited (NASDAQ: JZ) gained 24.1% to $0.7818 in pre-market trading. 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) surged 17.7% to $0.5884 in pre-market trading. 60 Degrees ...Benzinga · Jan 29, 2024

Bluejay Diagnostics Announces Closing of $3.5 Million Public OfferingACTON, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, today announced the closing of its previously announced public offering of 2,692,308 shares of the Company’s common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to 2,692,308 shares of common stock at a combined offering price of $1.30 per share (or pre-funded warrant in lieu thereof) and associated warrant. The warrants have an exercise price of $1.30 per share and are immediately exercisable upon issuance for a period of five years following the date of issuance.GlobeNewswire Inc. · Jan 2, 2024

Gold Moves Lower; US Crude Stocks Decline Last WeekU.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.27% to 37,758.26 while the NASDAQ rose 0.17% to 15,124.90. The S&P 500 also rose, gaining, 0.23% to 4,792.56. Check This Out: Microsoft To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Thursday Leading and Lagging Sectors Utilities shares jumped by 0.6 on Thursday. In trading on Thursday, energy shares fell by 0.9% Top Headline The EIA said crude oil inventories in the U.S. declined by 6.911 million barrels in the week ending Dec. 22, falling the most in four months and compared to market estimates of a 2.704 million-barrel decline. Equities Trading UP Microbot Medical Inc. (NASDAQ: MBOT) shares shot up 43% to $1.89 after the company announced the completion of its GLP pivotal pre-clinical study. Shares of Cingulate Inc. (NASDAQ: CING) got a boost, surging 129% to $9.14. On Tuesday, Cingulate received FDA guidance for CTx-1301 (dexmethylphenidate), its lead investigational product candidate for attention deficit hyperactivity disorder (ADHD). DouYu International Holdings Limited (NASDAQ: DOYU) shares were ...Benzinga · Dec 28, 2023

Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionShares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program. DouYu plans repurchase of up to $20 million of ordinary shares in the form of ADSS during period of up to twelve months commencing on Jan. 1, 2024. DouYu International shares jumped 14.2% to $0.8320 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Nova LifeStyle, Inc. (NASDAQ: NVFY) shares jumped 204% to $4.71. Cingulate Inc. (NASDAQ: CING) climbed 157.4% to $10.27. On Tuesday, Cingulate received FDA guidance for CTx-1301 (dexmethylphenidate), its lead investigational product candidate for attention deficit hyperactivity disorder (ADHD). Bone Biologics Corporation (NASDAQ: BBLG) gained 62.2% to $7.54. SenesTech, Inc. (NASDAQ: SNES) shares climbed 50.7% to $1.30. HC Wainwright & Co. analyst Amit Dayal maintained SenesTech with a Buy, adjusting target to $3.5 from $4. Microbot Medical Inc. (NASDAQ: MBOT) rose 38% to $1.8301 after the company announced the completion of its GLP pivotal pre-clinical study. Sidus Space, Inc. (NASDAQ: SIDU) gained 32% to $5.81. DatChat, Inc. (NASDAQ: DATS) rose 30% to $2.62. DatChat announced the release of its new AI social gaming platform and developer program for game designers and content creators. SEALSQ Corp (NASDAQ: LAES) gained 25% to $1.4424. SEALSQ disclosed that its post-quantum semiconductor technology, based on cutting-edge cryptographic algorithms, is specifically designed to withstand attacks from and secure cryptocurrency transactions against the looming threat of quantum computing. Ocean Biomedical, Inc. (NASDAQ: OCEA) surged 21.4% to $0.7299. DSS, Inc. (NYSE: DSS) jumped 21% to $0.1477. RenovoRx, Inc. (NASDAQ: RNXT) gained 20% to $1.2599. Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) rose 20% to $3.6250. The FDA recently approved the company's Zoryve topical foam, 0.3% for seborrheic dermatitis in individuals nine years and older. Envoy ...Benzinga · Dec 28, 2023

Crude Oil Down 1%; US Wholesale Inventories Fall In NovemberU.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 50 points on Thursday. The Dow traded up 0.14% to 37,708.15 while the NASDAQ rose 0.19% to 15,127.17. The S&P 500 also rose, gaining, 0.14% to 4,788.28. Check This Out: Microsoft To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Thursday Leading and Lagging Sectors Health care shares jumped by 0.5% on Thursday. In trading on Thursday, energy shares fell by 0.8%. Top Headline U.S. wholesale inventories declined by 0.2% month-over-month in November versus a 0.4% fall in the earlier month. Equities Trading UP Microbot Medical Inc. (NASDAQ: MBOT) shares shot up 40% to $1.85 after the company announced the completion of its GLP pivotal pre-clinical study. Shares of Cingulate Inc. (NASDAQ: CING) got a boost, surging 124% to $8.92. On Tuesday, Cingulate received FDA guidance for CTx-1301 (dexmethylphenidate), its lead investigational product candidate for attention deficit hyperactivity disorder (ADHD). SEALSQ Corp (NASDAQ: LAES) shares were also up, gaining 29% to $1.48 after ...Benzinga · Dec 28, 2023

BJDXBluejay Diagnostics, Inc. Common Stock

BJDX

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any BJDX yet.

Related Tickers

Earnings

Mkt Cap

$757,411

Volume

74.69K

Next Earnings

November 6th